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Multidrug-resistant Staphylococcus aureus (MRSA) has been reported as one of the 
main cause of nosocomial infection in the world and ranks as one of the most difficult 
bacteria to treat in hospitalized patients. Apparently, these multidrug resistance (MDR) 
traits are caused by an array of MDR efflux pumps in S. aureus. In this study, a panel of 
identified clinical S. aureus isolates were tested for their multidrug-resistance profile, 
detection of efflux genes and evaluated against selected phyto-compounds. From the 26 
bacterial isolates acquired from two teaching hospitals (HUKM and UMMC) and three 
ATCC S. aureus reference strains, 19 were confirmed as S. aureus isolates. Out of the 19 
isolates, 14 were confirmed as methicillin-resistant S. aureus (MetRSA) via phenotypic 
and genotypic methods. Fourteen MetRSA isolates exhibit multidrug-resistance against 
amikacin, erythromycin, gentamicin, norfloxacin, tetracycline and trimethoprim. A 
methicillin-sensitive S. aureus (MetSSA) with multidrug-resistant trait was also 
detected. Apart from vancomycin, mupirocin seems to be the most effective antibiotic 
against all S. aureus isolates. Two MDR efflux genes (mdeA and norA) were detected in 
all isolates tested. Out of the 19 isolates, 18 harboured the mdeA gene while 16 isolates 
 iii 
contained the norA gene. Active efflux activity in S. aureus was detected using modified 
minimum inhibitory concentration (MIC) assay with ethidium bromide and reserpine as 
the efflux substrate and efflux inhibitor respectively. From this assay, two MRSA 
clinical isolates and one ATCC 25923 S. aureus reference strain were selected as test 
strains against 37 selected phyto-compounds consisting of alkaloids, flavonoids, 
coumarins and essential oils. Nine compounds namely quinine, harmaline, piperine, 
cinnamon oil, dicumarol, eriodictyol-7,4’-dimethyl ether, 2’,4-dihydroxy-4’,5’,6’-
trimethoxychalcone and naringenin-4’-methyl ether exhibited good efflux inhibitory 
activity as compared to reserpine. The first two are alkaloids with a methoxyl group at 
position C6 of an indole and quinolone skeleton, respectively. The last three are 
flavonoids from different sub-classes of flavanone (eriodictyol-7,4’-dimethyl and ether 
naringenin-4’-methyl ether) and chalcone (2’,4-dihydroxy-4’,5’,6’-trimethoxychalcone). 
The similarity observed amongst member of the latter group is the presence of two 
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Staphylococcus aureus rintang-pelbagai-dadah (MRSA) telah dilaporkan menjadi punca 
utama jangkitan nosokomial di dunia dan tersenarai sebagai salah satu bakteria yang 
paling susah untuk di rawat pada pesakit hospital. Sifat rintang-pelbagai-dadah (MDR) 
ini adalah disebabkan oleh sekumpulan pam efluks pada S. aureus.  Di dalam kajian ini, 
satu panel pencilan klinikal S. aureus yang telah dikenalpasti sebagai rintang-pelbagai-
dadah dengan gen-gen efluks telah digunakan untuk menilai potensi perencatan efluks 
pada sebatian-fito terpilih. Daripada 26 pencilan bakteria yang diperoleh dari dua 
hospital pembelajaran (HUKM dan UMMC), 19 telah dipastikan sebagai pencilan S. 
aureus. Daripada 19 pencilan tersebut, 14 merupakan S. aureus rintang-methicilin 
(MetRSA) melalui ujian-ujian fenotipik dan genotipik. Empat belas pencilan MetRSA 
menunjukkan ciri rintang-pelbagai-dadah terhadap amikacin, erythromycin, gentamycin, 
norfloxacin, tetracycline dan trimethoprim. Satu S. aureus rintang-methicilin (MetSSA) 
dengan ciri rintang-pelbagai-dadah juga dikesan. Selain daripada vancomycin, 
mupirocin didapati yang paling efektif terhadap semua pencilan S. aureus. Dua gen 
efluks MDR (mdeA dan norA) di kesan daripada pencilan S. aureus yang ada. Lapan 
 v 
belas pencilan menunjukkan kehadiran gen mdeA manakala 16 pencilan mengandungi 
gen norA. Akiviti efluks yang aktif di kesan menggunakan kaedah kepekatan perencatan 
minimum (MIC) yang telah diubahsuai dengan ethidium bromide sebagai substrat efluks 
dan reserpine sebagai perencat efluks. Dari kaedah tersebut, dua pencilan klinikal 
MRSA dan satu strain rujukan S. aureus ATCC 25923 telah di pilih sebagai pencilan 
ujian terhadap 37 kompoun-fito terdiri dari kumpulan-kumpulan kompoun tumbuhan 
yang berbeza iaitu alkaloids, flavonoids, coumarins dan minyak pati. Sembilan sebatian 
iaitu quinine, harmaline, piperine, cinnamon oil, dicumarol, eriodictyol-7,4’-dimethyl 
ether, 2’,4-dihydroxy-4’,5’,6’-trimethoxychalcone dan naringenin-4’-methyl ether 
menunjukkan aktiviti perencatan efluks yang baik berbanding reserpine. Dua sebatian 
pertama adalah sebatian alkaloid dengan kumpulan metoksil pada posisi C6 di struktur 
asas indole dan quinolone. Tiga sebatian terakhir merupakan sebatian flavonoid dari 
sub-kelas flavanone (eriodictyol-7,4’-dimethyl dan ether naringenin-4’-methyl ether) 
dan chalcone (2’,4-dihydroxy-4’,5’,6’-trimethoxychalcone). Persamaan yang dapat 
diperhatikan adalah kehadiran dua kumpulan hidroksil pada struktur asas sebatian-
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Table 1: Results of the Gram differentiation, isolation and detection of S. aureus using phenotypic methods. Gram 
positive bacteria will have no colour change (transparent) and watery suspension in the L-alanine peptidase and 
3% KOH tests, respectively. Only S. aureus isolates would produce black colonies with yellow ring growth and 
agglutinates in the Vogel-Johnson agar and the Pastorex Staph-Plus Test respectively.  
 
Gram differentitation 
Isolates L-alanine  





N 391 No color change  Watery suspension Black colonies with yellow ring growth Agglutination 
N 441 No color change  Watery suspension Black colonies with yellow ring growth Agglutination 
N 829 No color change  Watery suspension Black colonies with yellow ring growth Agglutination 
N 850 No color change  Watery suspension Black colonies with yellow ring growth Agglutination 
N 1406 No color change  Watery suspension Black colonies with yellow ring growth Agglutination 
U 949 No color change  Watery suspension Black colonies with yellow ring growth Agglutination 
UM 1 No color change  Watery suspension Black colonies with yellow ring growth Agglutination 
UM 2 No color change  Watery suspension Black colonies with yellow ring growth Agglutination 
UM 3 No color change  Watery suspension Black colonies with yellow ring growth Agglutination 
UM 6 No color change  Watery suspension Black colonies with yellow ring growth Agglutination 
UM 7 No color change  Watery suspension Black colonies with yellow ring growth Agglutination 
UM 9 No color change  Watery suspension Black colonies with yellow ring growth Agglutination 
UM 10 No color change  Watery suspension Black colonies with yellow ring growth Agglutination 
UM 11 No color change  Watery suspension Black colonies with yellow ring growth Agglutination 
UM 13 No color change  Watery suspension Black colonies with yellow ring growth Agglutination 
UM 14 No color change  Watery suspension Black colonies with yellow ring growth Agglutination 
ATCC 25923 S. aureus No color change  Watery suspension Black colonies with yellow ring growth Agglutination 
ATCC 29213 S. aureus No color change  Watery suspension Black colonies with yellow ring growth Agglutination 
ATCC 33591 MetRSA No color change  Watery suspension Black colonies with yellow ring growth Agglutination 
ATCC 35218 E. coli Yellow coloration Sticky suspension N/A No agglutination 
ATCC 700728 E. coli Yellow coloration Sticky suspension N/A No agglutination 
   
Note: N/A = Not Applicable 
 
 
Table 3:  Antibiogram profile of S. aureus clinical isolates and ATCC strains against selected antibiotics. Disc diffusion 
breakpoints are based on the NCCLS guidelines except for * which are based on the BSAC guidelines.  
 
Antibiotics used / Diameter of inhibition zone (mm)  
ISOLATES AK AMP C DA E FD* CN MUP* NOR OX RD S TEC TE W V 
N 391 R R S R R R R S R R S R S R R S 
N 441 R R S S R S R S I R R R S R R S 
N 829; U 949 R R S S R S R S R R S R S R R S 
N 850 R R S S R R R S R R R R S R R S 
N 1406 R R S S R R R S R R S R S R R S 
UM 1 R R R S R I R S R R S R S R R S 
UM 2; UM 9 R R R S R S R S R R S R S R R S 
UM 3 R R S S S S R S R R R ND S R R S 
UM 6 S S S S S R S S S S S ND S S S S 
UM 7 S S S S S S S S S S S ND S S S S 
UM 10 R R R R R S R S R R S R S R R S 
UM 11 S R S S S R S S R S S ND I I S S 
UM 13 R R S S R R R S R R R R I R R S 
UM 14 R R R R R R R S R R S R S R R S 
ATCC 25923 S S S S I R S S S S S ND S S S S 
ATCC 29213 S S S S I R S I S S S ND I S S S 
ATCC 33591 S R R R R R S S S R S R S R S S 
Degree of susceptibility:  R = resistant; I = intermediate; S = susceptible; ND = Not determined 
 
Antibiotics used in this study :  AK = amikacin, 30 µg; AMP = ampicillin, 10 µg; C = chloramphenicol, 30 µg;  
DA = clindamycin, 2 µg; E = erythromycin, 15 µg; FD = fusidic acid, 10 µg;  
CN = gentamicin, 10 µg; MUP = mupirocin, 5 µg; NOR = norfloxacin, 10 µg;  
OX = oxacillin, 1 µg; RD = rifampicin, 5 µg; S = Streptomycin, 10 µg;  
TEC = teicoplanin, 30 µg; TE = tetracycline, 30 µg; W = trimethoprim, 5 µg;  
V =  vancomycin, 30 µg.  
Table 5:  In silico PCR results using the primers for norA and mdeA detection.  
 
Target Genes norA mdeA 
Staphylococci Strains No. of nucleotides mismatched allowed 
Amplification 
Results 




S. aureus RF122 0 + 0 + 
S. aureus strain Mu50 0 + 0 + 
S. aureus subsp. aureus COL 0 + 0 + 
S. aureus subsp. aureus MRSA252 2 - 0 + 
S. aureus subsp. aureus MSSA476 0 + 0 + 
S. aureus subsp. aureus MW2 0 + 0 + 
S. aureus subsp. aureus N315 0 + 0 + 
S. aureus subsp. aureus NCTC 8325 0 + 0 + 
S. aureus subsp. aureus USA300 0 + 0 + 
S. epidermidis ATCC 12228* 2 - 2 - 
 










Table 6:  Summary of the in silico nucleotide sequence alignment analysis for MSSA476 (norA) and MRSA252 (mdeA) 
against all available S. aureus database in NCBI using the BLASTN programme. 
 
Nucleotide sequence alignment analysis 
(% of homology) No. Ascension number 
S. aureus 
strains/gene/plasmid  
MSSA476 (norA) MRSA252 (mdeA) 
1 gi|47208328|dbj|BA000017.4| Mu50 100 99 
2 gi|49243355|emb|BX571857.1|  MSSA476 100 98 
3 gi|47118312|dbj|BA000033.2| MW2 100 98 
4 gi|47118324|dbj|BA000018.3| N315 100 99 
5 gi|216974|dbj|D90119.1|STANORA N/A 100 ND 
6 gi|57284222|gb|CP000046.1| COL 99 98 
7 gi|87201381|gb|CP000253.1| NCTC8325 99 98 
8 gi|87125858|gb|CP000255.1| USA300 99 98 
9 gi|693734|gb|S74031.1| ISP794 99 ND 
10 gi|82655308|emb|AJ938182.1| RF122 99 99 
11 gi|152647|gb|M62960.1|SA2NORA pSA209 99 ND 
12 gi|21328207|dbj|AB086042.1| N/A 100 ND 
13 gi|4115706|dbj|AB019536.1| norA23 94.5 ND 
14 gi|49240382|emb|BX571856.1| MRSA252 94 100 
15 gi|153054|gb|M97169.1|STANORAX N/A 93 ND 
16 gi|295163|gb|M80252.1|STANORA11 norA1199 93 ND 
17 gi|19745057|gb|AC090968.14| NCTC8325 (sabac-126) ND 98 
18 gi|27316888|gb|AE015929.1|* ATCC12228* 84.7 100 (only 20 nucleotides) 
 
            N/A = Not Available  ND = Not Detected 
 
 * S. epidermidis (control strain) 
 
Table 7:  Summary of the nucleotide sequence alignment analysis for norA using N441 and U949 against all available S. 
aureus database in NCBI using the BLASTN programme. 
 
Nucleotide sequence alignment analysis for norA 




1 gi|57284222|gb|CP000046.1| COL 100 100 
2 gi|87201381|gb|CP000253.1| NCTC8325 100 100 
3 gi|87125858|gb|CP000255.1| USA300 100 100 
4 gi|693734|gb|S74031.1| ISP794 100 100 
5 gi|47208328|dbj|BA000017.4| Mu50 99 99 
6 gi|49243355|emb|BX571857.1|  MSSA476 99 99 
7 gi|47118312|dbj|BA000033.2| MW2 99 99 
8 gi|47118324|dbj|BA000018.3| N315 99 99 
9 gi|216974|dbj|D90119.1|STANORA N/A 99 99 
10 gi|82655308|emb|AJ938182.1| RF122 98 98 
11 gi|152647|gb|M62960.1|SA2NORA pSA209 98 98 
12 gi|21328207|dbj|AB086042.1| N/A 99 99 
13 gi|4115706|dbj|AB019536.1| norA23 93.5 93.5 
14 gi|49240382|emb|BX571856.1| MRSA252 93.5 93.5 
15 gi|153054|gb|M97169.1|STANORAX N/A 92.5 92.5 
16 gi|295163|gb|M80252.1|STANORA11 norA1199 92 92.5 
17 gi|27316888|gb|AE015929.1|* ATCC12228* 81 81 
 
            N/A = Not Available  
 
 * S. epidermidis (control strain)
Table 8:  Summary of the nucleotide sequence alignment analysis for mdeA using N829 and UM2 against all available S. 
aureus database in NCBI using the BLASTN programme. 
 
Nucleotide sequence alignment analysis for mdeA 




1 gi|47208328|dbj|BA000017.4| Mu50 100 100 
2 gi|57284222|gb|CP000046.1| COL 100 100 
3a gi|87201381|gb|CP000253.1| NCTC8325 100 100 
3b gi|19745057|gb|AC090968.14| NCTC8325 (sabac-126) 100 100 
4 gi|87125858|gb|CP000255.1| USA300 100 100 
5 gi|49243355|emb|BX571857.1|  MSSA476 100 100 
6 gi|47118312|dbj|BA000033.2| MW2 100 100 
7 gi|47118324|dbj|BA000018.3| N315 100 100 
8 gi|82655308|emb|AJ938182.1| RF122 100 100 
9 gi|49240382|emb|BX571856.1| MRSA252 99 99 
 
